Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Mechanism of action  





2 Clinical use  





3 Safety  





4 References  














DDAIP






Српски / srpski
Srpskohrvatski / српскохрватски
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


DDAIP
Clinical data
Other namesDodecyl 2-N,N-dimethylaminopropionate; Dodecyl-2-(dimethylamino)propionate; N,N-Dimethylalanine dodecyl ester
Pharmacokinetic data
Bioavailability<1% (topical)
Protein binding>99%
MetabolismEsterase mediated
Elimination half-life5 hours
ExcretionUrinary
Identifiers
  • 2-Dimethylaminopropionic acid dodecyl ester (Decyl (C10) ester shown)

CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H36ClNO2
Molar mass321.93 g·mol−1
3D model (JSmol)
  • CCCCCCCCCCCCOC(=O)C(C)N(C)C

  • InChI=1S/C17H35NO2/c1-5-6-7-8-9-10-11-12-13-14-15-20-17(19)16(2)18(3)4/h16H,5-15H2,1-4H3

  • Key:HSMMSDWNEJLVRY-UHFFFAOYSA-N

  (verify)

DDAIP is a pharmaceutical ingredient added to topical products to increase penetration through the skin. Chemically, DDAIP is an esterofN,N-dimethylalanine and dodecanol, although as of now the structural formula shows an ester with decanol (C10) instead. DDAIP is typically formulated as its hydrochloride salt (DDAIP.HCl). This salt is a white crystalline solid with a melting range of 88-93 °C and is an amphiphilic molecule with a pKa of 4.87 that is soluble in water up to about 40% w/v. DDAIP is proprietary to NexMed USA, a subsidiary of Apricus Biosciences.[1]

Mechanism of action[edit]

DDAIP is a permeation enhancer[2] that temporarily changes the permeation dynamics of the lipid bilayer and opens up the tight junctions between skin cells so active drug molecules can be rapidly absorbed through the skin into systemic circulation.[3] It can also improve the solubility of compounds resulting in enhanced drug permeation.[4]

Clinical use[edit]

DDAIP hydrochloride is a functional inactive excipient currently used in the topical drug Vitaros, an alprostadil vasodilator cream used to treat erectile dysfunction. It is also used in MycoVa,[5]aterbinafine antifungal nail lacquer for onychomycosis currently in phase-III clinical trials.

Safety[edit]

Overall, about 5,000 patients have been exposed to this compound with no serious adverse events recorded. DDAIP is primarily metabolized by esterases on cell surfaces and plasma to N,N-dimethylalanine, which is further demethylated to alanine; and dodecanol which is oxidized to lauric acid, both naturally occurring compounds already present in the body.

References[edit]

  1. ^ US 6118020, Buyuktimkin S, Buyuktimkin N, "Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate", issued 12 September 2000, assigned to Nexmed Holdings Inc 
  • ^ Das D, Augustine J, Langenauer M. "Overcoming the Skin Barrier by Chemical Enhancements: A Formulator's Perspective". SP Formulations, LLC.
  • ^ Hadgraft J (2001). "Modulation of the barrier function of the skin". Skin Pharmacology and Applied Skin Physiology. 14 (Suppl 1): 72–81. doi:10.1159/000056393. PMID 11509910. S2CID 33920480.
  • ^ Michniak-Kohn B, Shah KR (March 2011). "Patchless Transdermal Drug Delivery (TDD)". TransDermal: 5–11.
  • ^ "Apricus Biosciences Reports Additional Analysis Showing That MycoVa Is As Effective For The Treatment Of Nail Fungus As The Current European Standard Of Care For Topical Therapy, Loceryl". GlobeNewswire. The Street. Archived from the original on 4 March 2016. Retrieved 16 March 2011.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=DDAIP&oldid=1214376362"

    Categories: 
    Excipients
    Amino acid derivatives
    Carboxylate esters
    Decyl esters
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Articles without EBI source
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Drugs missing an ATC code
    Drugs with no legal status
     



    This page was last edited on 18 March 2024, at 15:58 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki